A phase 1 study in healthy volunteers to investigate the safety, tolerability, and pharmacokinetics of VIR-2482: a monoclonal antibody for the prevention of severe influenza A illness
在健康志愿者中开展的 1 期研究旨在探讨 VIR-2482 的安全性、耐受性和药代动力学：一种用于预防严重甲型流感疾病的单克隆抗体
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.1
doi:10.1128/aac.01273-23
David Plotnik, Jennifer E Sager, Madhukar Aryal, Marie C Fanget, Alessia Peter, Michael A Schmid, Deborah Cebrik, Erik Mogalian, Keith Boundy, Wendy W Yeh, Paul Griffin, Maribel Reyes
